ABT
Healthcare
Abbott's Reported Sales Grew 14.5% But Comparable Growth Was 7%: GAAP EPS Fell To $0.53
Abbott's Q3 2026 sales rose 14.5% reported and 7.0% comparable, with Diagnostics +46.7% reported, while GAAP EPS fell to $0.53 and adjusted EPS rose 9.2% to $1.42.